CYCLERION THERAPEUTICS, INC. Proceeds from Issuance of Private Placement
CYCLERION THERAPEUTICS, INC. (CYCN) reported Proceeds from Issuance of Private Placement of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2023-03-22
- CYCLERION THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2022-12-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2021-12-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2021-09-30 was $6.00K.
- CYCLERION THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- CYCLERION THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2021 was $30.50M, a 25.79% increase from fiscal 2020.
- CYCLERION THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2020 was $24.25M, a 86.14% decline from fiscal 2019.
- CYCLERION THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2019 was $175.00M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 10-K · filed 2023-03-22 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $6.00K derived: sum of 2 quarters · filed 2023-03-22 | $30.50M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $30.50M 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $30.50M 10-Q · filed 2022-08-09 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $24.25M 10-K · filed 2022-02-24 | ||
| 2020-09-30 | $24.25M 10-Q · filed 2021-11-09 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $175.00M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $175.00M 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $175.00M 10-Q · filed 2020-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |